RE: Wary18 Aug 2022 12:13
I suspect they're holding back the Activ-2 results because, like Sprinter, they're inconclusive and they don't want to destroy the development of a drug they think has real potential.
I don't normally go in for silly conspiracy theories, but I think that makes more sense than assuming they're just dragging their heels in getting the data analysed. They've already done the hard part and were confident enough with what they saw to recommend it advance to the next stage. With the enormous amounts of time and money that have gone into these trials, analysing data they've already got would be a walk in the park.